Has Parikshit Sharma, MD received payments from drug or device companies?

Yes. Drug and device makers reported $462,263 in general payments to Parikshit Sharma, MD across 851 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Parikshit Sharma, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Parikshit Sharma, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Parikshit Sharma, MD

Clinical Cardiac Electrophysiology · Weston, FLNPI 1487985883

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $298,444 of the $462,263 with a category attached, or 64.6%. Medtronic accounts for 64.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $233,126 and has fallen 90.3% since, to $22,684 in 2025. Among clinical cardiac electrophysiology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$462,263in general payments, 2019–2025

Across 851 payments — averaging $543.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$297K
Biotronik Inc.$104K
Abbott$47K
Philips North America LLC$6K
Biosense Webster, Inc.$4K
Boston Scientific$3K
plus $2K from 7 others

$350,559in research payments, 2019–2025

Across 92 payments — averaging $3810.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$196K
Biosense Webster, Inc.$99K
Biotronik Inc.$31K
Medtronic$25K

What the payments were for

Consulting fees$30,2757%
Speaking & faculty fees$298,44465%
Grants$2,3841%
Travel & lodging$94,69620%
Food & beverage$36,3578%
Education$1070%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(3 entities)	420	$296,735
Biotronik Inc.	254	$103,730
Abbott	109	$46,694
Philips North America LLC	11	$5,763
Biosense Webster, Inc.	29	$4,202
Boston Scientific	19	$2,736
Volta Medical Inc	2	$1,538
Biosig Technologies, Inc.	2	$334
Impulse Dynamics (USA) Inc.	1	$168
Atricure, Inc.	1	$168
Elutia, Inc.	1	$132
Alnylam Pharmaceuticals Inc.	1	$35
Acutus Medical, Inc.	1	$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SelectSecure$21,469
Azure$16,274
Edora$15,120
Acticor$15,120
Rivacor$15,120
ENSITE PRECISION$12,848
Micra$10,463
Sentus$10,281
Plexa$10,281
Solia$8,780
BioMonitor$8,746
ENSITE$8,430
TENDRIL$5,128
(9520) IGT Devices Undivided$4,998
Allure CRT Pacemaker$4,708
Acticor 7 VR-T DX$3,930
Edora 8 DR-T$3,791
Rivacor 7 DR-T$3,791
Carto 3$3,509
Agilis NxT EP Introducer$3,400

How this compares

$462,263 in reported general payments places this provider in the 95th percentile of 249 clinical cardiac electrophysiology providers in Florida.

See all clinical cardiac electrophysiology providers in Florida →

Medicare billing

Part B allowed, 2024

$200,217

Medicare patients

867

Services billed

2,140

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	389	$544,830
XareltoRivaroxaban	147	$178,289
Dofetilide	97	$30,145
Amiodarone Hcl	257	$7,328
Metoprolol Succinate	353	$6,365
Flecainide Acetate	44	$1,852
Carvedilol	74	$998
Metoprolol Tartrate	73	$672
Diltiazem 24hr Er (Cd)Diltiazem Hcl	17	$426
Warfarin Sodium	24	$289
Lisinopril	20	$275
Losartan Potassium	13	$140
Amlodipine Besylate	23	$107
SotalolSotalol Hcl	13	$87

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Weston

Usman SiddiquiWinter Park$1.2M
Jose Osorio FilhoMiami$1.2M
David KenigsbergFort Lauderdale$1M
Raul WeissMiami Beach$887K
Naushad ShaikKissimmee$691K
Saumil OzaJacksonville$462K
Brian BetenskySarasota$412K
Antonio MorettaSarasota$312K
Marcelo JimenezAtlantis$295K
Yoel VivasDelray Beach$268K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →